<DOC>
	<DOC>NCT02682576</DOC>
	<brief_summary>The objective of the study is to define the analytical repeatability of quantifying flow-mediated dilation of the brachial artery using brachial artery ultrasound imaging using upper arm cuff occlusion.</brief_summary>
	<brief_title>Brachial Artery Ultrasound Imaging: A Repeatability Study</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>1. Men and women, ≥18 years old 2. Eastern Cooperative Oncology Group/Zubrod score performance status of 0, 1, or 2, determined within 7 days prior to FMD testing on Study Day 1 (Visit 1) 3. Written informed consent understood and signed; understanding of study procedures and ability to comply with them for the length of the study 1. Body mass index (BMI) &gt;50 kg/m2 2. Midupper arm circumference of arm selected for FMD testing &lt;17 cm or &gt;42 cm 3. Sinus arrhythmia (RR intervals vary by &gt;50%), atrial fibrillation, atrial flutter, multifocal atrial tachycardia, frequent (&gt;1 per 10sec strip) premature atrial or ventricular contractions (isolated, nonisolated, or alternating), documented by 12lead ECG with rhythm strip at the time of subject screening. 4. Clinical signs and/or symptoms of active viral or bacterial infections 5. Resting tremor or inability to remain still for the duration of the testing period 6. Systolic blood pressure (SBP) at rest of &gt;170 mmHg or diastolic blood pressure (DBP) at rest of ≥110 mmHg. 7. Diabetic subjects Type I or II 8. Previous intolerable adverse reaction(s) to vascular testing using an upper extremity occlusive pneumatic cuff</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>brachial artery ultrasound imaging</keyword>
	<keyword>flow-mediated dilation</keyword>
	<keyword>endothelium</keyword>
</DOC>